APA (7th ed.) Citation

M, G., S, N., M, V., M, G., I, K., D, A., . . . PA, L. (2026). Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathology. EMBO molecular medicine, 18(4), 1235. https://doi.org/10.1038/s44321-026-00387-8

Chicago Style (17th ed.) Citation

M, Gorzkiewicz, et al. "Sulfated Glycosaminoglycans Inhibit LCMV Entry and Modulate Antiviral Immunity and Pathology." EMBO Molecular Medicine 18, no. 4 (2026): 1235. https://doi.org/10.1038/s44321-026-00387-8.

MLA (9th ed.) Citation

M, Gorzkiewicz, et al. "Sulfated Glycosaminoglycans Inhibit LCMV Entry and Modulate Antiviral Immunity and Pathology." EMBO Molecular Medicine, vol. 18, no. 4, 2026, p. 1235, https://doi.org/10.1038/s44321-026-00387-8.